Measurement of brain atrophy in subcortical vascular disease: A comparison of different approaches and the impact of ischaemic lesions
暂无分享,去创建一个
Jean-Francois Mangin | Martin Dichgans | Philipp G. Sämann | Eric Jouvent | Hugues Chabriat | Mike O'Sullivan | Luc Bracoud | Chahin Pachai | Anand Viswanathan | Andreas Gschwendtner | M. O’Sullivan | M. Dichgans | H. Chabriat | C. Pachai | P. Sämann | E. Jouvent | A. Viswanathan | A. Gschwendtner | J. F. Mangin | L. Bracoud
[1] Michael Brady,et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.
[2] Sandra E. Black,et al. Misclassified Tissue Volumes in Alzheimer Disease Patients With White Matter Hyperintensities: Importance of Lesion Segmentation Procedures for Volumetric Analysis , 2008, Stroke.
[3] Martin Dichgans,et al. Hippocampal volume is an independent predictor of cognitive performance in CADASIL , 2009, Neurobiology of Aging.
[4] Karen J. Ferguson,et al. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[5] Stephen M. Smith,et al. A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..
[6] R. Henry,et al. Measurement of Whole‐Brain Atrophy in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[7] M. Dichgans,et al. Brain volume changes in CADASIL , 2006, Neurology.
[8] David H. Miller,et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.
[9] Marco Rovaris,et al. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial , 2004, The Lancet.
[10] Wei Wen,et al. Extent and Distribution of White Matter Hyperintensities in Stroke Patients: The Sydney Stroke Study , 2004, Stroke.
[11] H S Markus,et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL , 2001, Neurology.
[12] Lenore J. Launer,et al. Analysis and validation of automated skull stripping tools: A validation study based on 296 MR images from the Honolulu Asia aging study , 2006, NeuroImage.
[13] M. A. Horsfield,et al. Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences , 2003, Journal of the Neurological Sciences.
[14] S. Anand Trip,et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: Evidence that axonal loss is a substrate of MRI-detected atrophy , 2006, NeuroImage.
[15] Nick C Fox,et al. Imaging cerebral atrophy: normal ageing to Alzheimer's disease , 2004, The Lancet.
[16] Nick C. Fox,et al. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX , 2007, NeuroImage.
[17] David H. Miller,et al. Brain atrophy, interferon beta, and treatment trials in multiple sclerosis , 2004, The Lancet.
[18] J. Mangin,et al. Entropy minimization for automatic correction of intensity nonuniformity , 2000, Proceedings IEEE Workshop on Mathematical Methods in Biomedical Image Analysis. MMBIA-2000 (Cat. No.PR00737).
[19] H S Markus,et al. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[20] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[21] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[22] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[23] Chris Frost,et al. Cerebral Atrophy Measurement in Clinically Isolated Syndromes and Relapsing Remitting Multiple Sclerosis: A Comparison of Registration‐Based Methods , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[24] EricJouvent,et al. Brain Atrophy Is Related to Lacunar Lesions and Tissue Microstructural Changes in CADASIL , 2007 .
[25] L. Kappos,et al. MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS , 2007, Neurology.
[26] H. Möller,et al. Regional Distribution of White Matter Hyperintensities in Vascular Dementia, Alzheimer’s Disease and Healthy Aging , 2004, Dementia and Geriatric Cognitive Disorders.
[27] C Gössl,et al. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. , 2001, Radiology.
[28] M Rovaris,et al. Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis , 2004, Neurology.
[29] Martin Dichgans,et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. , 2006, Brain : a journal of neurology.
[30] Nick C Fox,et al. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. , 2000, Archives of neurology.
[31] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[32] Douglas G. Altman,et al. Measurement in Medicine: The Analysis of Method Comparison Studies , 1983 .
[33] J Mazziotta,et al. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.